Key Takeaways Exosome stem cell therapy uses cell-free vesicles instead of whole cells to support repair and calm inflammation. Exosomes carry proteins, lipids, and signaling molecules that support cell communication between damaged and healthy tissue. Research shows exosomes can help reduce inflammation and modulate immune response in chronic and autoimmune
Quick Summary A 2026 Nature study (MATCH trial) shows autologous macrophage therapy may improve transplant‑free survival in cirrhosis. After 4 years, ~70% of treated patients were alive without liver transplant vs. ~40% in standard care. The treatment uses the patient’s own immune cells (macrophages) to reduce inflammation and support repair.
Quick Summary Stem cell therapy is making measured progress toward treating age-related diseases like vision loss, frailty, and Parkinson’s, but broad age reversal remains unproven. Recent clinical trials show improved mobility in frailty patients, while Parkinson’s and vision repair trials aim to replace specific damaged cells. However, safety risks persist,
